Icosavax Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	63.24	59.91	280.72	15.5	23.08
Short-Term Investments	165.97	159.46	0	0	0
Cash & Cash Equivalents	229.21	219.37	280.72	15.5	23.08
Cash Growth	3.03%	-21.86%	1711.36%	-32.85%	-
Other Current Assets	6.1	4.55	5.83	0.66	0.21
Total Current Assets	235.31	223.91	286.55	16.16	23.29
Property, Plant & Equipment	14.38	14.76	1.08	0.01	0
Other Long-Term Assets	1.61	0	0	0	0
Total Long-Term Assets	15.99	14.76	1.08	0.01	0
Total Assets	251.3	238.68	287.63	16.17	23.29
Accounts Payable	1.24	2.89	3.9	1.92	0.8
Deferred Revenue	0	0	0.58	2.38	0
Current Debt	2.19	2.14	0	0	0
Other Current Liabilities	9.61	8.76	4.76	1.53	0.42
Total Current Liabilities	13.03	13.79	9.24	5.83	1.22
Long-Term Debt	5.89	6.66	0	4.95	0
Other Long-Term Liabilities	0	0.07	0.17	2.03	0.25
Total Long-Term Liabilities	5.89	6.73	0.17	6.98	0.25
Total Liabilities	18.92	20.52	9.41	12.81	1.47
Total Debt	8.07	8.8	0	4.95	0
Debt Growth	20.82%	-	-	-	-
Common Stock	491.35	404.39	372.29	0.4	0
Retained Earnings	-258.93	-185.83	-94.07	-27.1	-8.24
Comprehensive Income	-0.05	-0.4	0	0	0
Shareholders' Equity	232.38	218.16	278.22	-26.7	-8.24
Net Cash / Debt	221.14	210.57	280.72	10.55	23.08
Net Cash / Debt Growth	2.48%	-24.99%	2560.64%	-54.28%	-
Net Cash Per Share	4.42	5.30	15.63	4.70	3.50
Working Capital	222.28	210.13	277.32	10.33	22.07
Book Value Per Share	4.64	5.49	15.49	-11.89	-1.25

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).